Business
Directorate Change
Directorate Change.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 5196U NetScientific PLC 25 October 2017 \n\nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \n \nDirectorate Change\n \n \nLondon, UK - 25 October 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that Jonathan Paisner, Non-Executive Director, will be stepping down from his position on the Board with immediate effect, with the 25th October as his final day. \nCommenting on the news, Francois Martelet, Chief Executive Officer of NetScientific said: \"The Board of Directors and I would like to thank Jonathan for his contribution to NetScientific and wish him well in his future endeavours.\" \n \n \n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \n \nAbout NetScientific \n \nNetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net\n \n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END BOABZLLLDBFBFBZ\n ","length":3639,"tagName":"div"}]